DiCE Molecules
Rajesh M. has an extensive work experience in the pharmaceutical and biotech industry. Rajesh is currently working as the Executive Director of Clinical Operations at DICE Therapeutics, Inc., a subsidiary of Eli Lilly and Company. Prior to that, they held the position of VP of Clinical Operations at Adanate. Rajesh's previous roles include being a Clinical Program Director at Genentech, a Clinical Program Manager at Takeda Pharmaceuticals, and a Manager of Clinical Studies at Astellas Pharma. Rajesh has been actively involved in the development and management of clinical programs throughout their career.
Rajesh M. holds a Master of Business Administration (MBA) degree in Marketing and Finance from DePaul Driehaus College of Business. Rajesh also has a Bachelor of Science (BS) degree in Clinical Laboratory Science/Medical Technology/Technologist from Michigan State University College of Natural Science. Additionally, they obtained a Master of Science (MS) degree in Medical Clinical Sciences/Graduate Medical Studies from Wayne State University School of Medicine.
DiCE Molecules
DiCE Molecules designs and develops innovative therapies in immunology for patients with debilitating disease. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, they are developing oral alternatives to medicines currently limited to injectable forms.